On Wednesday October 18, theRuban Rose association announced the ten winners of its Prix Ruban Rose 2023, donating 1,850,000 euros to breast cancer research. The awards ceremony was held at the French National Assembly, in the presence of President Yaël Braun-Pivet and master of ceremonies Leïla Kaddour-Boudadi.
Although research continues to progress, 1 in 8 women is still affected by breast cancer. Research plays a crucial role in detecting, treating, supporting and curing the disease.
Medical and scientific advances are leading to a deeper understanding of breast cancer and its origins, with the aim of improving treatment paths and reinforcing preventive measures. That's why, since 2003, the Pink Ribbon association has been working alongside researchers, doctors and associations to support their projects and contribute to the fight against breast cancer.
In 20 years, nearly 8 million euros have been donated to 98 breast cancer research projects!
The Pink Ribbon Awards support fundamental, translational and clinical cancer research. They are also awarded for remarkable advances or innovations in screening techniques, reconstructive surgery, psychology or improving the quality of life of women and men affected by this disease.
The 20th edition of the Pink Ribbon Awards rewarded 10 innovative research projects dedicated to the fight against breast cancer. The projects selected by the Jury and validated by the Association's Committee are ambitious, bold and innovative, and aim to bring about a significant change in the fight against the disease or in the daily lives of patients:
- 1 Grand Prix Ruban Rose de la Recherche - with an endowment of 300,000 euros
- 4 Prix Ruban Rose Avenir - each worth 200,000 euros
- 5 Pink Ribbon Quality of Life Awards - each worth 150,000 euros
Pr Florence JOLY wins the Grand Prix Ruban Rose for Research
The Grand Prix de la Recherche Ruban Rose is a grant awarded to expert doctors or researchers who are internationally renowned and whose work is recognized by the scientific community.
Awarded by the President of the French National Assembly, Ms Yaël Braun-Pivet, this year's prize honors the work of Professor Florence Joly, a medical oncologist at the Centre Baclesse, on understanding the neurological toxicities of
cancer treatments.
Project title: "Understanding, preventing, and treating cognitive sequelae after breast cancer treatment"
Despite spectacular progress, breast cancer treatment can have serious side effects, including cognitive disorders. Whether it's difficulty remembering things, fatigue, loss of self-confidence or general disorganization, these problems are difficult to diagnose because they are so commonplace in everyday life. Nevertheless, they can have a strong and lasting impact on patients' quality of life, without any solutions being proposed.
Against this backdrop, the aim of this project is twofold. On the one hand, Florence Joly wants to better characterize these disorders and understand the pathophysiological mechanisms behind them, by looking for genomic and inflammatory biomarkers predictive of their onset.
On the other hand, she will work on the development of original, non-medicinal approaches to care, based on the use of new technologies and adapted physical activity, including sessions with neuropsychologists.
A HUGE BRAVO TO PR FLORENCE JOLY FOR HER HARD WORK AND EXCELLENCE!
Virginie PREVOST wins a Ruban Rose Quality of Life Award
This year, the five projects selected for the Pink Ribbon Quality of Life Awards focused on two major themes:
"living better" with cancer, and "cancer and work", with the aim of significantly and rapidly improving patients' quality of life, whether in physical, emotional, relational or professional terms, throughout their treatment and beyond.
With its project " Shared meditation involving people with cancer, caregivers, and third parties: added value compared to meditation conducted with patients? IMPLIC 2, a randomized study," Virginie Prevost, a researcher at the Baclesse Center within the ANTICIPE team, was awarded a Ruban Rose Quality of Life Prize.
Having cancer is an ordeal that generates great suffering for patients, and a great deal of fatigue for caregivers. While numerous studies have already shown that mindfulness meditation is beneficial for both patients and caregivers, the originality of this project lies in proposing meditation workshops in which patients, caregivers and third parties (patients' relatives) participate together. The hypothesis is that such practices will result in greater health benefits - and consequently a greater improvement in quality of life - than when meditation is practiced in isolation.
To verify this, a clinical study will be set up. Patients, divided into two groups with or without nursing staff and third parties, will be invited to meditate for a total of 36 hours over a 6-month period. Improved quality of life is expected to include reduced stress, less pain anda greater sense of self-efficacy.
CONGRATULATIONS TO VIRGINIE PREVOST FOR THIS QUALITY OF LIFE AWARD!
